Table of Contents
ISRN Infectious Diseases
Volume 2013 (2013), Article ID 540948, 8 pages
http://dx.doi.org/10.5402/2013/540948
Clinical Study

Eosinopenia as a Prognostic Marker in Patients with Peritonitis

Department of Surgery, Government NSCB Medical College, Jabalpur 482003, India

Received 16 April 2012; Accepted 15 June 2012

Academic Editors: G. Calleri, E. Çiftçi, K. Peoc'H, M. R. Pourshafie, and F. Su

Copyright © 2013 T. S. Jagdeesh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Abidi, I. Khoudri, J. Belayachi et al., “Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units,” Critical Care, vol. 12, no. 2, article R59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. M. Ho and S. C. Towler, “A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study,” Anaesthesia and Intensive Care, vol. 37, no. 3, pp. 450–456, 2009. View at Google Scholar · View at Scopus
  3. H. Shaaban, S. Daniel, R. Sison, J. Slim, and G. Perez, “Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?” Journal of Critical Care, vol. 25, no. 4, pp. 570–575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Holland, M. Alkhalil, S. Chandromouli, A. Janjua, and M. Babores, “Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease,” Respirology, vol. 15, no. 1, pp. 165–167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. I. López de Toro Martín Consuegra, M. Sánchez Casado, S. Rodríguez Villar et al., “Evaluation of eosinopenia as an infection marker in critical care patients,” Medicina Intensiva/Sociedad Española de Medicina Intensiva y Unidades Coronarias, vol. 34, no. 4, pp. 246–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Mishra, D. Sharma, and V. K. Raina, “A simplified prognostic scoring system for peptic ulcer perforation in developing countries,” Indian Journal of Gastroenterology, vol. 22, no. 2, pp. 49–53, 2003. View at Google Scholar · View at Scopus
  7. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Google Scholar · View at Scopus
  8. D. Sharma, M. Bhansali, A. Saxena, and V. K. Raina, “Treatment of typhoid ileal perforation by resection and temporary ileostomy,” Indian Journal of Gastroenterology, vol. 21, no. 5, pp. 205–206, 2002. View at Google Scholar · View at Scopus
  9. J. R. Krause and D. R. Boggs, “Search for eosinopenia in hospitalized patients with normal blood leukocyte concentration,” American Journal of Hematology, vol. 24, no. 1, pp. 55–63, 1987. View at Google Scholar · View at Scopus
  10. S. N. Khosla, A. Anand, U. Singh, and A. Khosla, “Haematological profile in typhoid fever,” Tropical Doctor, vol. 25, no. 4, pp. 156–158, 1995. View at Google Scholar · View at Scopus
  11. S. Jog, R. Soman, T. Singhal, C. Rodrigues, A. Mehta, and F. D. Dastur, “Enteric fever in Mumbai—clinical profile, sensitivity patterns and response to antimicrobials,” Journal of Association of Physicians of India, vol. 56, pp. 237–240, 2008. View at Google Scholar · View at Scopus
  12. C. Kuvandik, I. Karaoglan, M. Namiduru, and I. Baydar, “Predictive value of clinical and laboratory findings in the diagnosis of the enteric fever,” New Microbiologica, vol. 32, no. 1, pp. 25–30, 2009. View at Google Scholar · View at Scopus
  13. D. A. Bass, T. A. Gonwa, and P. Szejda, “Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation,” Journal of Clinical Investigation, vol. 65, no. 6, pp. 1265–1271, 1980. View at Google Scholar · View at Scopus
  14. A. J. Wardlaw, “Eosinophils in the 1990s: new perspectives on their role in health and disease,” Postgraduate Medical Journal, vol. 70, no. 826, pp. 536–552, 1994. View at Google Scholar · View at Scopus
  15. M. Montesanti, G. Testa, C. Biagi, and F. Bartolini, “Trend of circulating eosinophils in healthy children and children suffering from infective diseases. A retrospective study,” Minerva Pediatrica, vol. 49, no. 5, pp. 179–186, 1997. View at Google Scholar · View at Scopus
  16. R. M. Dorizzi, E. Polati, P. Sette, A. Ferrari, P. Rizzotti, and A. Luzzani, “Procalcitonin in the diagnosis of inflammation in intensive care units,” Clinical Biochemistry, vol. 39, no. 12, pp. 1138–1143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Singh, A. Mishra, D. Sharma, and U. Somashekar, “A simple prognostic scoring system for typhoid ileal perforation peritonitis,” Tropical Doctor, vol. 40, no. 4, pp. 203–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Schuetz, M. Christ-Crain, and B. Müller, “Procalcitonin and other biomarkers for the assessment of disease severity and guidance of treatment in bacterial infections,” Advances in Sepsis, vol. 6, no. 3, pp. 82–89, 2008. View at Google Scholar
  19. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G. Y. Perret, “Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis,” Critical Care Medicine, vol. 34, no. 7, pp. 1996–2003, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. U. Jensen, B. Lundgren, L. Hein et al., “The Procalcitonin And Survival Study (PASS)—a Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients,” BMC Infectious Diseases, vol. 8, article 91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. M. Martin, F. Priestap, H. Fisher et al., “A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry,” Critical Care Medicine, vol. 37, no. 1, pp. 81–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Ferrer, A. Artigas, M. M. Levy et al., “Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain,” Journal of the American Medical Association, vol. 299, no. 19, pp. 2294–2303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Beale, K. Reinhart, F. M. Brunkhorst et al., “Promoting global research excellence in severe sepsis (PROGRESS): lessons from an international sepsis registry,” Infection, vol. 37, no. 3, pp. 222–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Agrawal, D. Sharma, and V. K. Raina, “Arterial pH and arterial oxygenation are not essential for risk stratification in perforation peritonitis,” Indian Journal of Gastroenterology, vol. 18, no. 1, pp. 5–6, 1999. View at Google Scholar · View at Scopus
  25. D. Sharma, “Scoring systems for intra-abdominal sepsis: the science of predicting risks,” Indian Journal of Surgery, vol. 64, no. 2, pp. 125–147, 2002. View at Google Scholar
  26. C. M. Jones and T. Athanasiou, “Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests,” Annals of Thoracic Surgery, vol. 79, no. 1, pp. 16–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Prakash, D. Sharma, A. Saxena et al., “Effect of Candida infection on outcome in patients with perforation peritonitis,” Indian Journal of Gastroenterology, vol. 27, no. 3, pp. 107–109, 2008. View at Google Scholar · View at Scopus